Comparisons of norcantharidin cytotoxic effects on oral cancer cells and normal buccal keratinocytes

Oral Oncology

Volumn 39, Issue 1, 2003, Pages 19-26

  Kok, S H ^a,b   Hong, C Y ^a,b   Kuo, M Y P ^a,b   Lee, C H K ^a   Lee, J J ^b   Lou, I U ^a   Lee, M S ^a   Hsiao, M ^c   Lin, S K ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Buccal keratinocytes; Cytotoxicity; Norcantharidin; Oral cancer

Indexed keywords

DNA; NORCANTHARIDIN;

ANOIKIS; ARTICLE; CELL GROWTH; CELL STRAIN KB; CELL TYPE; COLONY FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DNA STRAND; DNA SYNTHESIS; DNA SYNTHESIS INHIBITION; HUMAN; HUMAN CELL; KERATINOCYTE; MORPHOLOGY; MOUTH CARCINOMA; PRIORITY JOURNAL;

BICYCLO COMPOUNDS, HETEROCYCLIC; CELL DIVISION; DNA DAMAGE; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; KERATINOCYTES; MOUTH MUCOSA; MOUTH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0037211088     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(01)00129-4     Document Type: Article

References (23)

1. Notani P.N. Epidemiology and prevention of head and neck cancer: a global view. Saranath D. Contemporary Issues in Oral Cancer. 2000;1-29 Oxford University Press, New Delhi.
2. Vokes E.E., Weichselbaum R.R., Lippman S.M., Hong W.K. Head and neck cancer. N. Engl. J. Med. 328(3):1993;184-194.
3. IARC. Betel-quid and areca-nut chewing. IARC Monogr Eval Carcinog Risk Chem Hum 1985;37:137-202.
4. Bourhis J., Pignon J.P. Meta-analyses in head and neck squamous cell carcinoma. What is the role of chemotherapy? Hematol. Oncol. Clin. North Am. 13(4):1999;769-775.
5. Pignon J.P., Bourhis J., Domenge C., Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet. 355(9208):2000;949-955.
6. Lo T.C., Wiley A.L. Jr., Ansfield F.J., Brandenburg J.H., Davis H.L. Jr., Gollin F.F.et al. Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized study. Am. J. Roentgenol. 126(2):1976;229-235.
7. Carrel J.E., Eisner T., Lo T.C., Wiley A.L. Jr., Ansfield F.J., Brandenburg J.H.et al. Cantharidin: potent feeding deterrent to insects. Science. 183(126):1974;755-757.
8. Graziano M.J., Waterhouse A.L., Casida J.E. Cantharidin poisoning associated with specific binding site in liver. Biochem. Biophys. Res. Commun. 149(1):1987;79-85.
9. Graziano M.J., Pessah I.N., Matsuzawa M., Casida J.E. Partial characterization of specific cantharidin binding sites in mouse tissues. Mol. Pharmacol. 33(6):1988;706-712.
10. Wang G.S. Medical uses of mylabris in ancient China and recent studies. J. Ethnopharmacol. 26(2):1989;147-162.
11. Hong C.Y., Huang S.C., Lin S.K., Lee J.J., Chueh L.L., Lee C.H.et al. Norcantharidin-induced post-G(2)/M apoptosis is dependent on wild-type p53 gene. Biochem. Biophys. Res. Commun. 276(1):2000;278-285.
12. McCluskey A., Bowyer M.C., Collins E., Sim A.T.R., Sakoff J.A., Baldwin M.L.et al. Anhydride modified cantharidin analogues: synthesis, inhibition of protein phosphatases 1 and 2A and anticancer activity. Bioorg. Med. Chem. Lett. 10(15):2000;1687-1690.
13. Yang E.B., Tang W.Y., Zhang K., Cheng L.Y., Mack P.O. Norcantharidin inhibits growth of human HepG2 cell-transplanted tumor in nude mice and prolongs host survival. Cancer Lett. 117(1):1997;93-98.
14. Liu X.H., Blazsek I., Comisso M., Legras S., Marion S., Quittet P.et al. Effects of norcantharidin, a protein phosphatase type-2A inhibitor, on the growth of normal and malignant haemopoietic cells. Eur. J. Cancer. 31A(6):1995;953-963.
15. Li J., Farthing P.M., Ireland G.W., Thornhill M.H. IL-1 alpha and IL-6 production by oral and skin keratinocytes: similarities and differences in response to cytokine treatment in vitro. J. Oral Pathol. Med. 25(4):1996;157-162.
16. Lin S.K., Wang C.C., Huang S., Lee J.J., Chiang C.P., Lan W.H.et al. Induction of dental pulp fibroblast matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 gene expression by interleukin-1alpha and tumor necrosis factor-alpha through a prostaglandin-dependent pathway. J. Endod. 27(3):2001;185-189.
17. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65(1-2):1983;55-63.
18. Lin X., Ramamurthi K., Mishima M., Kondo A., Christen R.D., Howell S.B. P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatin. Cancer Res. 61(4):2001;1508-1516.
19. Olive P.L., Lin X., Ramamurthi K., Mishima M., Kondo A., Christen R.D.et al. DNA precipitation assay: a rapid and simple method for detecting DNA damage in mammalian cells. Environ. Mol. Mutagen. 11(4):1988;487-495.
20. Martins E.A., Chubatsu L.S., Meneghini R., Lin X., Ramamurthi K., Mishima M.et al. Role of antioxidants in protecting cellular DNA from damage by oxidative stress. Mutat. Res. 250(1-2):1991;95-101.
21. Haffty B.G., Lin X., Ramamurthi K., Mishima M., Kondo A., Christen R.D.et al. Concurrent chemoradiation in the treatment of head and neck cancer. Hematol. Oncol. Clin. North Am. 13(4):1999;719-742.
22. Saikumar P., Dong Z., Mikhailov V., Denton M., Weinberg J.M., Venkatachalam M.A.et al. Apoptosis: definition, mechanisms, and relevance to disease. Am. J. Med. 107(5):1999;489-506.
23. Vock E.H., Lutz W.K., Ilinskaya O., Vamvakas S. Discrimination between genotoxicity and cytotoxicity for the induction of DNA double-strand breaks in cells treated with aldehydes and diepoxides. Mutat. Res. 441(1):1999;85-93.